Aptose Biosciences
APTO
#10464
Rank
HK$33.95 M
Marketcap
HK$13.30
Share price
0.00%
Change (1 day)
755.03%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -HK$0.17 Billion

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.2 Billion, an increase over its 2023 earnings that were of -HK$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.17 Billion-16.98%
2024 -HK$0.2 Billion-51.82%
2023 -HK$0.41 Billion22.9%
2022 -HK$0.34 Billion-34.91%
2021 -HK$0.51 Billion17.36%
2020 -HK$0.44 Billion107.65%
2019 -HK$0.21 Billion-7.73%
2018 -HK$0.23 Billion160.68%
2017 -HK$86.87 Million-20.27%
2016 -HK$0.11 Billion28.71%
2015 -HK$84.66 Million
2013 -HK$47.99 Million
2010 -HK$40.87 Million-8.31%
2009 -HK$44.57 Million
2006 -HK$82.65 Million-156.93%
2005 HK$0.14 B-185.16%
2004 -HK$0.18 Billion458.58%
2003 -HK$30.52 Million-63.66%
2002 -HK$83.97 Million-8.04%
2001 -HK$91.31 Million16.73%
2000 -HK$78.23 Million294.99%
1999 -HK$19.81 Million-6.51%
1998 -HK$21.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-HK$0.27 Billion 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-HK$0.45 Billion 175.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-HK$0.49 Billion 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA